NDC product
Reltone 400 mg
NDC 80056-144 · Intra-Sana Laboratories
Key facts
| Product NDC | 80056-144 |
|---|---|
| Proprietary name | Reltone 400 mg |
| Nonproprietary name | Ursodiol |
| Substances | URSODIOL |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Intra-Sana Laboratories |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA205789 |
| Pharmacologic classes | Bile Acid [EPC], Bile Acids and Salts [CS] |
| Marketing start | Jul 1, 2020 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: